Shell's Twin Divestment Push Signals a Sharper Focus on Core Profit Centres
Published on 08/24/2026 at 18:13 | Redaktion boerse-global.de
The energy major is executing a portfolio overhaul on two fronts at once. While a deal to offload its entire European onshore renewables business to TotalEnergies moves closer to completion, reports emerged on Monday that Shell is also courting buyers for its US chemicals assets — a sale that could fetch as much as $8 billion.
The Financial Times reported that ExxonMobil, LyondellBasell, Apollo Global Management and Kuwait Petroleum have all expressed interest in the American chemical plants, which span Louisiana, Texas and Pennsylvania. Non-binding bids were reportedly submitted as early as July, and a transaction at the upper end of that range would hand Shell significant firepower for further shareholder returns or strategic investments.
A Pattern of Pruning
The US chemicals disposal would extend a well-established divestment streak. Shell already sold its Singapore chemicals hub in 2025 and offloaded the Mobile, Alabama refinery in 2022. The European renewables sale to TotalEnergies, first reported roughly three weeks ago, covers the entirety of Shell's onshore wind and solar operations across the continent. Neither transaction carries a disclosed price tag, but the strategic logic is consistent: exit capital-intensive businesses with thin margins and redeploy resources toward oil, gas and chemicals — segments where returns have been markedly stronger.
That thesis was reinforced over the summer. Late June saw the closure of the $1.3 billion Jiffy Lube International sale to a Monomoy Capital Partners subsidiary, complete with a long-term lubricant supply agreement. July brought the $1.8 billion disposal of Solenergi Power Private Limited — parent of the Sprng Energy group — to Aditya Birla Renewables.
Should investors sell immediately? Or is it worth buying Shell?
The Canadian Counterweight
Even as Shell trims its portfolio at the edges, it is doubling down elsewhere. The proposed acquisition of ARC Resources, agreed in April, carries an equity value of roughly $13.6 billion, with ARC shareholders receiving a mix of cash and Shell stock. The deal is slated to close in the second half of the year, subject to shareholder approval and regulatory clearance, and Shell has earmarked around $4 billion of this year's investment guidance for the Canadian expansion.
Operating Momentum Provides Cover
The divestment campaign is unfolding from a position of operational strength. Second-quarter adjusted earnings came in at $9.8 billion, supported by an operating cash flow north of $21 billion. The chemicals division posted its best performance in more than five years, anchored by a record showing at the Pennsylvania petrochemical complex, while refineries ran at 102 percent utilisation during a period of fat margins, with production tilted toward middle distillates such as jet fuel.
Cost discipline is also tracking ahead of plan. Shell banked $700 million in structural savings during the first half, progressing toward a multi-year target of $5 billion to $7 billion. Those efficiencies underpin the capital-return programme that has driven the shares up 27 percent since the start of the year.
Market Timing and Technicals
The timing of a potential US chemicals sale looks deliberate. With refining margins robust and oil prices firm — a tailwind that lifted second-quarter results for Shell and rival BP alike — the company is well positioned to negotiate from strength. Geopolitical supply disruptions in the Middle East have also pushed oil majors toward American projects, a trend that could bolster the appeal of Shell's US chemicals footprint to prospective buyers.
The stock has absorbed the news flow with composure. Shell closed Friday at €39.94, down a marginal 0.2 percent on the day, but the 30-day picture shows a gain of 3.1 percent and the year-to-date advance stands at 28 percent. The shares sit just 3.3 percent below their 52-week high of €41.32, reached in late March, with the relative strength index near 63 — a slightly stretched but far from critical reading.
Investors have two dates circled on the calendar: the second-quarter interim dividend payment on 21 September, followed by third-quarter results on 29 October. Shell has indicated it intends to complete its current buyback programme before that earnings release. Should the US chemicals sale materialise in the coming months, it would reinforce the narrative of a company executing its stated strategy with unusual discipline — a story the market has already begun to reward.
Ad
Shell Stock: New Analysis - 24 August
Fresh Shell information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
